The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
D | Dermatologicals | |
2
|
D06 | Antibiotics and chemotherapeutics for dermatological use | |
3
|
D06A | Antibiotics for topical use | |
4
|
D06AX | Other antibiotics for topical use | |
5
|
D06AX14 |
| Active Ingredient |
|---|
|
Ozenoxacin is a non-fluorinated quinolone with a dual inhibitory activity against bacterial DNA replication enzymes, DNA gyrase A and topoisomerase IV. Ozenoxacin is characterized by its potency and bactericidal activity against clinical bacterial isolates involved in skin infections, including S. aureus and S. pyogenes. |
| Document | Type | Information Source | |
|---|---|---|---|
| DUBINE Cream | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| OZANEX Cream | MPI, CA: SPM | Health Products and Food Branch (CA) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.